Biobanking Consumables Market Size and Growth Forecast: Global Insights and Analysis

Report ID : 1297339 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Biobanking Consumables Market is categorized based on Sample Type (Blood Products, Tissue Samples, Cell Lines, Nucleic Acids, Other Biological Samples) and Product Type (Consumables, Equipment, Services) and Application (Clinical Research, Drug Development, Personalized Medicine, Genetic Research, Other Applications) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

As of 2023, the Biobanking Consumables Market size stood at $5.5 billion and is expected to attain $12 billion by 2033, growing at a 8.1% CAGR from 2024 through 2033. The report includes diverse segments and offers an analysis of trends and factors substantially impacting the market.

The biobanking consumables market is a substantive part of an industry that is constantly changing.Demands for personal medicine, more sophisticated diagnosis and new treatment options are on the rise. Biobanks are used more often and for more purposes which also spikes the interest from tissue sample users. This increase in demand highlights the significance of consumables such as biological samples collection devices, cryostorage containers, laboratory equipment and other materials needed to handle biological samples. Such products are critical when one tries to preserve the form and functionality of biological samples.

As focus on precision medicine increases, the biobanking consumables industry grows as well. Different stakeholders from research institutions, pharmaceutical companies, and healthcare organizations want more reliable and effective biobanking solutions to meet their goals. Consequently, new forms of compliance and innovative products and services are introduced to the market for more efficient sample management and strive to meet research target goals. With this shift towards enhanced research focus, there is plethora of opportunity for sellers and manufacturers and biobanking consumables.

As we go more profound into the biobanking consumables market, here is an overview of some key trends, challenges, and growth drivers that define this area. Chronic diseases are on the rise, as is the need of biobanking in clinical trials, all of which translate to a booming market. By utilizing our comprehensive market research insights, stakeholders will be able to circumvent the complexities that this environment presents and make business decisions that further their biobanking efforts.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Illumina Inc., BD (Becton, Dickinson and Company), VWR International LLC, PerkinElmer Inc., LGC Limited, STEMCELL Technologies Inc.
SEGMENTS COVERED	By Sample Type - Blood Products, Tissue Samples, Cell Lines, Nucleic Acids, Other Biological Samples By Product Type - Consumables, Equipment, Services By Application - Clinical Research, Drug Development, Personalized Medicine, Genetic Research, Other Applications By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Biobanking Consumables Market Dynamics

The Biobanking Consumables Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Biobanking Consumables Market

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Qiagen N.V.
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• BD (Becton
• Dickinson and Company)
• VWR International LLC
• PerkinElmer Inc.
• LGC Limited
• STEMCELL Technologies Inc.

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved